What Researchers Did
Researchers treated 230 patients with acute carbon monoxide poisoning, with 203 receiving hyperbaric oxygen (HBO) based on specific neurological criteria and 27 receiving normobaric oxygen.
What They Found
Out of 230 patients, 4 died, and 7 experienced minor neurological problems within two weeks of discharge, which resolved within one month. Additionally, 2 patients were re-hospitalized for neuropsychiatric sequelae, recovering within 3 to 6 months, and neither admission status nor carboxyhemoglobin levels predicted outcomes.
What This Means for Canadian Patients
Canadian patients experiencing acute carbon monoxide poisoning, especially those with neurological symptoms or a history of unconsciousness, may benefit from hyperbaric oxygen therapy. This treatment could potentially prevent severe delayed neurological problems, suggesting broader indications for its use than currently common.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's observational design and lack of a randomized comparison between hyperbaric and normobaric oxygen for all patients limit the generalizability of its findings.